Published in Bioorg Med Chem on August 01, 2004
(E)-N-(3,3-Diphenyl-allyl-idene)-4-nitro-aniline. Acta Crystallogr Sect E Struct Rep Online (2012) 2.05
(E)-N-(3,3-Diphenyl-allyl-idene)-3-nitro-aniline. Acta Crystallogr Sect E Struct Rep Online (2012) 2.03
(E)-2,2'-[3-(2-Nitro-phen-yl)prop-2-ene-1,1-di-yl]bis-(3-hy-droxy-5,5-dimethyl-cyclo-hex-2-en-1-one). Acta Crystallogr Sect E Struct Rep Online (2011) 2.01
The N terminus of monoamine transporters is a lever required for the action of amphetamines. J Biol Chem (2010) 1.58
2,2-[(E)-3,3-Diphenyl-prop-2-ene-1,1-di-yl]bis-(3-hy-droxy-cyclo-hex-2-en-1-one). Acta Crystallogr Sect E Struct Rep Online (2011) 1.56
3-Hy-droxy-2-[(2E)-1-(2-hy-droxy-6-oxocyclo-hex-1-en-1-yl)-3-(2-meth-oxy-phen-yl)prop-2-en-1-yl]cyclo-hex-2-en-1-one. Acta Crystallogr Sect E Struct Rep Online (2011) 1.54
Ginsenosides: are any of them candidates for drugs acting on the central nervous system? CNS Drug Rev (2007) 1.42
Identification of farnesyl pyrophosphate and N-arachidonylglycine as endogenous ligands for GPR92. J Biol Chem (2008) 1.37
Enhanced learning and memory in mice lacking Na+/Ca2+ exchanger 2. Neuron (2003) 1.35
2,2'-[(E)-3-(4-Nitro-phen-yl)prop-2-ene-1,1-di-yl]bis-(3-hy-droxy-5,5-dimethyl-cyclo-hex-2-en-1-one). Acta Crystallogr Sect E Struct Rep Online (2012) 1.28
Visualization of dopamine transporter trafficking in live neurons by use of fluorescent cocaine analogs. J Neurosci (2009) 1.26
9-[(E)-2-(2-Meth-oxy-phen-yl)ethen-yl]-3,4,5,6,7,9-hexa-hydro-2H-xanthene-1,8-dione. Acta Crystallogr Sect E Struct Rep Online (2012) 1.23
Parkin ubiquitinates and promotes the degradation of RanBP2. J Biol Chem (2005) 1.19
(E)-2,2'-[3-(4-Fluoro-phen-yl)prop-2-ene-1,1-di-yl]bis-(3-hy-droxy-5,5-dimethyl-cyclo-hex-2-en-1-one). Acta Crystallogr Sect E Struct Rep Online (2013) 1.16
(E)-3,3,6,6-Tetra-methyl-9-(2-nitro-styr-yl)-3,4,5,6,7,9-hexa-hydro-1H-xanthene-1,8(2H)-dione. Acta Crystallogr Sect E Struct Rep Online (2012) 1.11
(E)-N-[(E)-3-(4-Nitro-phen-yl)allyl-idene]naphthalen-1-amine. Acta Crystallogr Sect E Struct Rep Online (2013) 1.07
The novel cellular mechanism of human 5-HT6 receptor through an interaction with Fyn. J Biol Chem (2006) 1.06
(E)-9-(4-Chloro-styr-yl)-3,4,5,6,7,9-hexa-hydro-2H-xanthene-1,8-dione. Acta Crystallogr Sect E Struct Rep Online (2012) 1.06
5- And 6-exocyclic products, cis-2,3,5-trisubstituted tetrahydrofurans, and cis-2,3,6-trisubstituted tetrahydropyrans via Prins-type cyclization. J Org Chem (2008) 1.06
Functional interaction of neuronal Cav1.3 L-type calcium channel with ryanodine receptor type 2 in the rat hippocampus. J Biol Chem (2007) 1.05
Dyrk1A phosphorylates alpha-synuclein and enhances intracellular inclusion formation. J Biol Chem (2006) 1.03
(E)-2,2'-[3-(2-Nitro-phen-yl)prop-2-ene-1,1-di-yl]bis-(3-hy-droxy-cyclo-hex-2-en-1-one). Acta Crystallogr Sect E Struct Rep Online (2011) 1.02
Activation of NMDA receptors increases proliferation and differentiation of hippocampal neural progenitor cells. J Cell Sci (2007) 1.00
17Beta-estradiol inhibits high-voltage-activated calcium channel currents in rat sensory neurons via a non-genomic mechanism. Life Sci (2002) 0.99
Inhibition of recombinant Ca(v)3.1 (alpha(1G)) T-type calcium channels by the antipsychotic drug clozapine. Eur J Pharmacol (2009) 0.98
Neuroprotective effects of ginsenoside Rg3 against homocysteine-induced excitotoxicity in rat hippocampus. Brain Res (2006) 0.97
Increased production of tumor necrosis factor-alpha induces apoptosis after traumatic spinal cord injury in rats. J Neurotrauma (2003) 0.97
Gintonin, a ginseng-derived novel ingredient, evokes long-term potentiation through N-methyl-D-aspartic acid receptor activation: involvement of LPA receptors. Mol Cells (2012) 0.97
Prevention of ginsenoside-induced desensitization of Ca2+-activated Cl- current by microinjection of inositol hexakisphosphate in Xenopus laevis oocytes: involvement of GRK2 and beta-arrestin I. J Biol Chem (2003) 0.96
Inhibitory effect of ginsenosides on NMDA receptor-mediated signals in rat hippocampal neurons. Biochem Biophys Res Commun (2002) 0.94
Characteristics of ginsenoside Rg3-mediated brain Na+ current inhibition. Mol Pharmacol (2005) 0.93
Novel GSK-3beta inhibitors from sequential virtual screening. Bioorg Med Chem (2007) 0.92
(E)-2,2'-[3-(4-Chloro-phen-yl)prop-2-ene-1,1-di-yl]bis-(3-hy-droxy-5,5-di-methyl-cyclo-hex-2-en-1-one). Acta Crystallogr Sect E Struct Rep Online (2013) 0.92
5-Exocyclic products, 2,3,5-trisubstituted tetrahydrofurans via Prins-type cyclization. Org Lett (2006) 0.92
Ginsenoside Rg3 antagonizes NMDA receptors through a glycine modulatory site in rat cultured hippocampal neurons. Biochem Biophys Res Commun (2004) 0.92
(E)-9-(4-Fluoro-styr-yl)-3,3,6,6-tetra-methyl-3,4,5,6,7,9-hexa-hydro-2H-xanthene-1,8-dione. Acta Crystallogr Sect E Struct Rep Online (2013) 0.92
Stereospecificity of ginsenoside Rg3 action on ion channels. Mol Cells (2004) 0.91
(E)-N-(3,3-Di-phenyl-allyl-idene)naph-thal-en-1-amine. Acta Crystallogr Sect E Struct Rep Online (2013) 0.91
Physical interaction of Jab1 with human serotonin 6 G-protein-coupled receptor and their possible roles in cell survival. J Biol Chem (2010) 0.91
Ginsenoside Rg3 inhibits human Kv1.4 channel currents by interacting with the Lys531 residue. Mol Pharmacol (2007) 0.90
(E)-N-(3,3-Di-phenyl-allyl-idene)-2-(tri-fluoro-meth-yl)aniline. Acta Crystallogr Sect E Struct Rep Online (2013) 0.90
Effects of ginsenoside Rg2 on human neuronal nicotinic acetylcholine receptors. J Pharmacol Exp Ther (2002) 0.90
Mutations Leu427, Asn428, and Leu431 residues within transmembrane domain-I-segment 6 attenuate ginsenoside-mediated L-type Ca(2+) channel current inhibitions. Biol Pharm Bull (2009) 0.90
Effects of amyloid-β peptides on voltage-gated L-type Ca(V)1.2 and Ca(V)1.3 Ca(2+) channels. Mol Cells (2011) 0.90
Highly stereoselective synthesis of 2,5-disubstituted 3-vinylidene tetetrahydrofurans via Prins-type cyclization. Org Lett (2005) 0.88
Direct interaction and functional coupling between voltage-gated CaV1.3 Ca2+ channel and GABAB receptor subunit 2. FEBS Lett (2010) 0.87
Quercetin enhances human α7 nicotinic acetylcholine receptor-mediated ion current through interactions with Ca(2+) binding sites. Mol Cells (2010) 0.87
Cloning and heterologous expression of a Ca2+-activated chloride channel isoform from rat brain. Biol Pharm Bull (2006) 0.87
Design and synthesis of a novel photoaffinity ligand for the dopamine and serotonin transporters based on 2beta-carbomethoxy-3beta-biphenyltropane. J Med Chem (2006) 0.87
Novel quinazolinone derivatives as 5-HT7 receptor ligands. Bioorg Med Chem (2007) 0.86
Epigenetic regulation of cholinergic receptor M1 (CHRM1) by histone H3K9me3 impairs Ca(2+) signaling in Huntington's disease. Acta Neuropathol (2013) 0.86
Synthesis and biological evaluation of benzoisothiazole derivatives possessing N,N-dimethylformimidamide group as 5-HT₆ receptor antagonists. Bioorg Med Chem (2012) 0.86
KST5468, a new T-type calcium channel antagonist, has an antinociceptive effect on inflammatory and neuropathic pain models. Pharmacol Biochem Behav (2010) 0.86
FCCP depolarizes plasma membrane potential by activating proton and Na+ currents in bovine aortic endothelial cells. Pflugers Arch (2001) 0.85
IKKbeta inhibitors identification part II: ligand and structure-based virtual screening. Bioorg Med Chem (2010) 0.85
Arylpiperazine-containing pyrimidine 4-carboxamide derivatives targeting serotonin 5-HT(2A), 5-HT(2C), and the serotonin transporter as a potential antidepressant. Bioorg Med Chem Lett (2010) 0.85
20(S)-ginsenoside Rh2, a newly identified active ingredient of ginseng, inhibits NMDA receptors in cultured rat hippocampal neurons. Eur J Pharmacol (2006) 0.85
Neuroprotective effects of ginseng saponins against L-type Ca2+ channel-mediated cell death in rat cortical neurons. Biochem Biophys Res Commun (2007) 0.85
Synthesis of 3,4-dimethylidene oxacycles through Prins-type cyclization of allenylmethylsilanes. Chem Asian J (2011) 0.84
Stilbene derivatives as human 5-HT(6) receptor antagonists from the root of Caragana sinica. Biol Pharm Bull (2010) 0.84
Ginsenosides inhibit NMDA receptor-mediated epileptic discharges in cultured hippocampal neurons. Arch Pharm Res (2004) 0.84
Effects of ginsenoside Rg2 on the 5-HT3A receptor-mediated ion current in Xenopus oocytes. Mol Cells (2003) 0.84
Protective effects of ginseng saponins on 3-nitropropionic acid-induced striatal degeneration in rats. Neuropharmacology (2005) 0.84
Discovery and development of heat shock protein 90 inhibitors as anticancer agents: a review of patented potent geldanamycin derivatives. Expert Opin Ther Pat (2013) 0.84
GABA(B) receptor-mediated ERK1/2 phosphorylation via a direct interaction with Ca(V)1.3 channels. Neurosci Lett (2012) 0.83
ST1936 stimulates cAMP, Ca2+, ERK1/2 and Fyn kinase through a full activation of cloned human 5-HT6 receptors. Eur J Pharmacol (2011) 0.83
Effects of ginsenosides, active ingredients of Panax ginseng, on development, growth, and life span of Caenorhabditis elegans. Biol Pharm Bull (2007) 0.83
Coupling of semiconductor nanowires with neurons and their interfacial structure. Nanoscale Res Lett (2009) 0.83
Effects of protopanaxatriol-ginsenoside metabolites on rat N-methyl-d-aspartic Acid receptor-mediated ion currents. Korean J Physiol Pharmacol (2012) 0.83
T-type Ca2+ channel blockers suppress the growth of human cancer cells. Bioorg Med Chem Lett (2008) 0.82
Ginseng saponins induce store-operated calcium entry in Xenopus oocytes. Br J Pharmacol (2004) 0.82
Modulation of Ca(v)3.1 T-type Ca2+ channels by the ran binding protein RanBPM. Biochem Biophys Res Commun (2008) 0.82